Characteristics of the protective subcellular coccidioidal T27K vaccine
- PMID: 17363436
- DOI: 10.1196/annals.1406.016
Characteristics of the protective subcellular coccidioidal T27K vaccine
Abstract
While the whole killed spherule vaccine, protective in mice and monkeys, did not prevent coccidioidal disease in humans, the 27K vaccine, a soluble derivative, retains protective activity in mice with little irritant action. Gel filtration and anion exchange fractions of thimerosal-inactivated spherules (T27K), when administered with alum adjuvant, also protect mice against lethal respiratory coccidioidal challenge. However, the superb protection afforded by T27K antigens is maintained for some 3 months, but may then diminish. This appears unrelated to the aging of the mice. Prolongation of the protective action may require addition of a different adjuvant or administration of booster doses of vaccine.
Similar articles
-
Dendritic cell-based vaccine against coccidioides infection.Ann N Y Acad Sci. 2007 Sep;1111:269-74. doi: 10.1196/annals.1406.013. Epub 2007 Mar 15. Ann N Y Acad Sci. 2007. PMID: 17363430 Review.
-
Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.Infect Immun. 1998 May;66(5):2342-5. doi: 10.1128/IAI.66.5.2342-2345.1998. Infect Immun. 1998. PMID: 9573127 Free PMC article.
-
Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.Vaccine. 2006 Jan 23;24(4):495-500. doi: 10.1016/j.vaccine.2005.07.092. Epub 2005 Aug 15. Vaccine. 2006. PMID: 16181709
-
Molecular cloning and expression of a cDNA encoding a Coccidioides posadasii 1,2-alpha-mannosidase identified in the coccidioidal T27K vaccine by immunoproteomic methods.Ann N Y Acad Sci. 2007 Sep;1111:164-80. doi: 10.1196/annals.1406.015. Epub 2007 Mar 15. Ann N Y Acad Sci. 2007. PMID: 17363438
-
The public health need and present status of a vaccine for the prevention of coccidioidomycosis.Ann N Y Acad Sci. 2007 Sep;1111:259-68. doi: 10.1196/annals.1406.035. Epub 2007 Mar 7. Ann N Y Acad Sci. 2007. PMID: 17344529 Review.
Cited by
-
Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii.Infect Immun. 2008 Dec;76(12):5553-64. doi: 10.1128/IAI.00885-08. Epub 2008 Oct 13. Infect Immun. 2008. PMID: 18852250 Free PMC article.
-
The public health impact of coccidioidomycosis in Arizona and California.Int J Environ Res Public Health. 2011 Apr;8(4):1150-73. doi: 10.3390/ijerph8041150. Epub 2011 Apr 15. Int J Environ Res Public Health. 2011. PMID: 21695034 Free PMC article. Review.
-
The Host Response to Coccidioidomycosis.J Fungi (Basel). 2024 Feb 25;10(3):173. doi: 10.3390/jof10030173. J Fungi (Basel). 2024. PMID: 38535182 Free PMC article. Review.
-
Progress Toward a Human Vaccine Against Coccidioidomycosis.Curr Fungal Infect Rep. 2012 Dec 1;6(4):235-244. doi: 10.1007/s12281-012-0105-y. Curr Fungal Infect Rep. 2012. PMID: 23585916 Free PMC article.
-
Distance from construction site and risk for coccidioidomycosis, Arizona, USA.Emerg Infect Dis. 2014 Sep;20(9):1464-71. doi: 10.3201/eid2009.131588. Emerg Infect Dis. 2014. PMID: 25148473 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical